Correlation Between Lisata Therapeutics and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Lisata Therapeutics and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lisata Therapeutics and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lisata Therapeutics and Lumos Pharma, you can compare the effects of market volatilities on Lisata Therapeutics and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lisata Therapeutics with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lisata Therapeutics and Lumos Pharma.
Diversification Opportunities for Lisata Therapeutics and Lumos Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Lisata and Lumos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lisata Therapeutics and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Lisata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lisata Therapeutics are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Lisata Therapeutics i.e., Lisata Therapeutics and Lumos Pharma go up and down completely randomly.
Pair Corralation between Lisata Therapeutics and Lumos Pharma
If you would invest (100.00) in Lumos Pharma on December 19, 2024 and sell it today you would earn a total of 100.00 from holding Lumos Pharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Lisata Therapeutics vs. Lumos Pharma
Performance |
Timeline |
Lisata Therapeutics |
Lumos Pharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Lisata Therapeutics and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lisata Therapeutics and Lumos Pharma
The main advantage of trading using opposite Lisata Therapeutics and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lisata Therapeutics position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.Lisata Therapeutics vs. Lixte Biotechnology Holdings | Lisata Therapeutics vs. Imunon Inc | Lisata Therapeutics vs. Rezolute | Lisata Therapeutics vs. XOMA Corporation |
Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |